Artificial bile inhibits bile salt-induced gallbladder glycoprotein release in vitro.
The more hydrophobic bile salts cause rapid release of preformed gallbladder mucin and other glycoproteins by gallbladder explants in vitro, whereas the less hydrophobic bile salts elicit a lesser response. This study was designed to determine (a) whether this short-term effect was matched by a sustained increase in glycoprotein secretion over 24 hr and (b) whether it occurred when bile salts were presented in model biles rather than aqueous solution. Although 3 mmol/L taurodeoxycholate in aqueous solution increased release of preformed gallbladder glycoprotein to 843% of control values after 30 min incubation (p < 0.001), no significant increase was observed after 24 hr. The more prolonged exposure also reduced precursor uptake by 32% (p < 0.05) and inhibited synthesis of new glycoprotein by 24% (p < 0.05). Moreover, the stimulatory effect of taurodeoxycholate on release of gallbladder glycoprotein was much reduced when it was presented in model biles rather than in aqueous solution. Nor was there any difference between the effects of more hydrophobic vs. less hydrophobic bile salts when presented in model biles. Aqueous solutions of the more hydrophobic bile salts induce a rapid release of gallbladder glycoprotein in vitro but do not produce a sustained increase in glycoprotein secretion. Their effect is liable to be prevented in vivo by interaction between bile salts and the other lipids in gallbladder bile.
O'Leary
D P
DP
Evans Memorial Department of Clinical Research, University Hospital, Boston, Massachusetts 02118.
D000818:Animals; D001646:Bile / Q000502:physiology*; D001647:Bile Acids and Salts / Q000502:physiology*; D005704:Gallbladder / Q000378:metabolism*; D006023:Glycoproteins / Q000378:metabolism*; D006168:Guinea Pigs; D009924:Organ Culture Techniques; D013657:Taurodeoxycholic Acid / Q000494:pharmacology; D013997:Time Factors
D001647:Bile Acids and Salts; D006023:Glycoproteins; D013657:Taurodeoxycholic Acid